Stockscreener 앱 받기
25.36
1.16%
0.29
시간 외 거래:
25.36
전일 마감가:
$25.07
열려 있는:
$25.22
하루 거래량:
154.36K
Relative Volume:
0.53
시가총액:
$1.76B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-2.01%
1개월 성능:
-6.39%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$24.70
$26.36
1주일 범위
$23.32
$26.93
52주 변동 폭
$18.84
$29.43
Alamar Biosciences Inc Stock (ALMR) Company Profile
명칭
Alamar Biosciences Inc
전화
510-626-9888
주소
47071 BAYSIDE PARKWAY, FREMONT
Compare ALMR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALMR
Alamar Biosciences Inc
|
25.36 | 1.69B | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Alamar Biosciences Inc 주식(ALMR)의 최신 뉴스
Alamar Biosciences Inc. (ALMR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alamar Biosciences, Inc. Revenue Breakdown – NASDAQ:ALMR - TradingView
Alamar Biosciences, Inc. (ALMR) stock price, news, quote and history - Yahoo Finance Australia
Alamar Biosciences, Inc. (ALMR) Stock Price, News, Quote & History - Yahoo! Finance Canada
ALZpath Broadens Strategic Agreement with Alamar Biosciences to Advance Clinical Diagnostics for Alzheimer's Disease - Yahoo Finance
Alamar Biosciences, Inc. (ALMR) Price Book Value - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Alamar Biosciences (NASDAQ: ALMR) adjusts board after director death - Stock Titan
This company just filed for an IPO three months after its parent company went public - The Business Journals
Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026 - The Manila Times
Alamar Biosciences Sets Aug. 10 Results Webcast; Replay to Follow - Stock Titan
IPOs juice biotech real estate (if only a little), but vacancy still climbs and lease rates tumble - The Business Journals
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases - Indovizka.com
Alamar Biosciences 與多間頂尖研究大學合作啟動全國計劃，旨在推動神經退行性疾病相關的血漿生物標記研究 - GlobeNewswire Inc.
BofA Securities Adjusts Alamar Biosciences Price Target to $30 From $27 - Moomoo
Alamar Biosciences, Inc. Stock 12‑Month Price Target Raised to $30.6, Implies 8% Upside - TradingView
21,000 blood samples to fuel open Alzheimer’s biomarker and AI project - Stock Titan
Alamar Biosciences Launches National-Scale ADRD Proteomics Initiative for Open Biomarker Discovery - Quiver Quantitative
Alamar Biosciences Partners with Leading Research - GlobeNewswire
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling - riauone.com
Alamar’s platform to feature in 140+ presentations at AAIC - Investing.com India
Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer’s Biomarker Profiling - Koreabizwire
Alamar Biosciences to Present NULISA Alzheimer’s Data in More Than 140 AAIC Posters and Sessions - Quiver Quantitative
Alamar Biosciences NULISA Data Featured in More Than 140 - GlobeNewswire
Form 13D/A Alamar Biosciences For: 7 July By Investing.com - Investing.com Nigeria
Sands Capital reports 6.1% Alamar Biosciences (ALMR) stake and board change - Stock Titan
Price to book forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research - Koreabizwire
Alamar Biosciences Launches First Commercial Blood-Based eMTBR-Tau Assay for Alzheimer’s Disease - Quiver Quantitative
Price to sales forward of Alamar Biosciences, Inc. – NASDAQ:ALMR - TradingView
Sherpa Funds Hold 7.2% of Alamar Biosciences (NASDAQ: ALMR) - Stock Titan
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Index - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Value Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 2000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000E Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to Russell 3000 Growth Benchmark - marketscreener.com
Alamar Biosciences, Inc.(NasdaqGS:ALMR) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Alamar Biosciences Inc (ALMR:UW): Stock Price, Quote and News - BNN Bloomberg
Alamar Biosciences, Inc. (ALMR) Earnings Yield (TTM) - Zacks Investment Research
Alamar Biosciences, Inc. (ALMR) Cash From Operations (Quarterly) - Zacks Investment Research
Alamar Biosciences, Inc.(NasdaqGS: ALMR) added to S&P TMI Index - marketscreener.com
Alamar Biosciences, Inc. (ALMR) - Zacks Investment Research
Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics - Koreabizwire
Alamar Biosciences Inc (ALMR) 재무 분석
Alamar Biosciences Inc (ALMR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Alamar Biosciences Inc 주식 (ALMR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Naclerio Nicholas | Director |
Apr 20 '26 |
Buy |
17.00 |
235,294 |
3,999,998 |
507,076 |
1.04%
11.95%
자본화:
|
볼륨(24시간):